Lower values ​​of d-ROMs Test in cystic fibrosis after intake whey protein.

This is one of the most interesting data to emerge from a study published in the latest issue of the prestigious journal "Progress in Nutrition," now available in digital version.

The book, dedicated to the whey protein and born from the collaboration of international experts, is divided into three sections.
The first section is devoted to the biochemical aspects, the second to clinical aspects, in accordance with the most current scientific literature, and the third to the results of recent trials conducted in Italy with the use of these precursors of "physiological modulators" in the field of pathology chronic-degenerative diseases.

The proteins from whey, after the pioneering observations by Italian-Canadian Gustavo Bounous (in the seventies), are now entering in the scene of the most popular supplements for nutritionists, especially in the area of ​​supportive care. One of the secrets of the effectiveness of these proteins is that they are rich in cysteine ​​and cystine, the natural precursor of glutathione, that is the most important intracellular antioxidant. In fact, in one of the trials reported in the last section of the work in question, performed at the Gaslini Institute of Genoa, the treatment with a special formula based on whey proteins delipidized and delactosed  (Prother^TM ) was accompanied by a statistically significant lower values ​​of d-ROMs Test in patients with cystic fibrosis (De Alessandri, Minicucci, Iorio et al.).

This study confirms once again the reliability of the Panel Carratelli to monitor the oxidative balance, especially in relation to supplementation.